MFG
EBS icon

Magnus Financial Group’s Emergent Biosolutions EBS Stock Holding History

Magnus Financial Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,214
Closed -$333K – 406
2020
Q2 		$333K Buy
+4,214
New +$314K 0.04% 305
2019
Q1 		– Sell
-4,443
Closed -$263K – 520
2018
Q4 		$263K Buy
+4,443
New +$286K 0.07% 235

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Magnus Financial Group's EBS Position: Q3 2020 in Review

Magnus Financial Group sold out of Emergent Biosolutions (EBS) in Q3 2020, closing a stake of 4,214 shares — an estimated $333K sold.

Magnus Financial Group first reported a position in EBS in Q4 2018 and held it in 2 quarters. The position peaked at $333K in Q2 2020. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • Magnus Financial Group reported no remaining Emergent Biosolutions position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 4,214 Emergent Biosolutions shares in Q3 2020, an estimated $333K.
  • Magnus Financial Group first reported a position in Emergent Biosolutions in Q4 2018 and held it in 2 quarters.
  • Magnus Financial Group's Emergent Biosolutions position peaked at $333K in Q2 2020.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.